249 related articles for article (PubMed ID: 17643414)
1. Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression.
Geraets L; Moonen HJ; Brauers K; Gottschalk RW; Wouters EF; Bast A; Hageman GJ
Eur J Pharmacol; 2007 Nov; 573(1-3):241-8. PubMed ID: 17643414
[TBL] [Abstract][Full Text] [Related]
2. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
3. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells.
Geraets L; Moonen HJ; Brauers K; Wouters EF; Bast A; Hageman GJ
J Nutr; 2007 Oct; 137(10):2190-5. PubMed ID: 17884996
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.
Kauppinen TM; Gan L; Swanson RA
Biochim Biophys Acta; 2013 Aug; 1833(8):1985-91. PubMed ID: 23597856
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells.
Nakajima H; Nagaso H; Kakui N; Ishikawa M; Hiranuma T; Hoshiko S
J Biol Chem; 2004 Oct; 279(41):42774-86. PubMed ID: 15302869
[TBL] [Abstract][Full Text] [Related]
6. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
Geraets L; Haegens A; Weseler AR; Brauers K; Vernooy JH; Wouters EF; Bast A; Hageman GJ
Eur J Pharmacol; 2010 Mar; 629(1-3):132-9. PubMed ID: 19962977
[TBL] [Abstract][Full Text] [Related]
8. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
9. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice.
Sriram CS; Jangra A; Gurjar SS; Hussain MI; Borah P; Lahkar M; Mohan P; Bezbaruah BK
Pharmacol Biochem Behav; 2015 Jun; 133():83-91. PubMed ID: 25863272
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
Wang Z; Li Y; Lv S; Tian Y
J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
13. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
14. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.
Xu X; Chua CC; Zhang M; Geng D; Liu CF; Hamdy RC; Chua BH
Brain Res; 2010 Jul; 1343():206-12. PubMed ID: 20451505
[TBL] [Abstract][Full Text] [Related]
15. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1.
Chang WJ; Alvarez-Gonzalez R
J Biol Chem; 2001 Dec; 276(50):47664-70. PubMed ID: 11577079
[TBL] [Abstract][Full Text] [Related]
16. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
Alano CC; Kauppinen TM; Valls AV; Swanson RA
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model.
Ahmad SF; Zoheir KM; Bakheet SA; Ashour AE; Attia SM
Cytokine; 2014 Aug; 68(2):76-85. PubMed ID: 24845796
[TBL] [Abstract][Full Text] [Related]
18. Silencing of poly(ADP-ribose) polymerase-1 suppresses hyperstretch-induced expression of inflammatory cytokines in vitro.
Wang J; Liu L; Xia Y; Wu D
Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):556-64. PubMed ID: 24829399
[TBL] [Abstract][Full Text] [Related]
19. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
20. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Lin CH; Lin PH
Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
